PRONOVA XP Trademark

Trademark Overview


On Thursday, February 1, 2007, a trademark application was filed for PRONOVA XP with the United States Patent and Trademark Office. The USPTO has given the PRONOVA XP trademark a serial number of 77096876. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 7, 2007. This trademark is owned by Device Partners Inc.. The PRONOVA XP trademark is filed in the Medical Instrument Products category with the following description:

drug eluting stent
pronova xp

General Information


Serial Number77096876
Word MarkPRONOVA XP
Filing DateThursday, February 1, 2007
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 7, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesdrug eluting stent

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2007
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDevice Partners Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinston Salem, NC 27106

Trademark Events


Event DateEvent Description
Wednesday, November 7, 2007ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 7, 2007ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 27, 2007NON-FINAL ACTION E-MAILED
Tuesday, March 27, 2007NON-FINAL ACTION WRITTEN
Wednesday, March 21, 2007ASSIGNED TO EXAMINER
Friday, March 2, 2007TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 6, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords


pronova stent eluting drug